NO971895L - Inhibitorer av apolipoprotein <beta>-syntesen - Google Patents

Inhibitorer av apolipoprotein <beta>-syntesen

Info

Publication number
NO971895L
NO971895L NO971895A NO971895A NO971895L NO 971895 L NO971895 L NO 971895L NO 971895 A NO971895 A NO 971895A NO 971895 A NO971895 A NO 971895A NO 971895 L NO971895 L NO 971895L
Authority
NO
Norway
Prior art keywords
apolipoprotein
inhibitors
beta
synthesis
Prior art date
Application number
NO971895A
Other languages
English (en)
Other versions
NO311937B1 (no
NO971895D0 (no
Inventor
Jan Heeres
Leo Jacobus Jozef Backx
Robert Jozef Maria Hendrickx
Luc Alfons Leo Van Der Eycken
Didier Robert Guy G Courcelles
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/455,304 external-priority patent/US5521186A/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO971895L publication Critical patent/NO971895L/no
Publication of NO971895D0 publication Critical patent/NO971895D0/no
Publication of NO311937B1 publication Critical patent/NO311937B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
NO19971895A 1994-10-27 1997-04-24 Inhibitorer av apolipoprotein <beta>-syntesen NO311937B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94203120 1994-10-27
US08/455,304 US5521186A (en) 1994-10-27 1995-05-31 Apolipoprotein-β synthesis inhibitors
PCT/EP1995/004111 WO1996013499A1 (en) 1994-10-27 1995-10-19 Apolipoprotein-b synthesis inhibitors

Publications (3)

Publication Number Publication Date
NO971895L true NO971895L (no) 1997-04-24
NO971895D0 NO971895D0 (no) 1997-04-24
NO311937B1 NO311937B1 (no) 2002-02-18

Family

ID=26136684

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971895A NO311937B1 (no) 1994-10-27 1997-04-24 Inhibitorer av apolipoprotein <beta>-syntesen

Country Status (30)

Country Link
US (1) US5929075A (no)
EP (1) EP0788496B1 (no)
JP (1) JP3025907B2 (no)
KR (1) KR100227231B1 (no)
CN (1) CN1068000C (no)
AP (1) AP779A (no)
AT (1) ATE198889T1 (no)
AU (1) AU697744C (no)
BG (1) BG63694B1 (no)
BR (1) BR9509436A (no)
CA (1) CA2203274C (no)
CY (1) CY2256B1 (no)
CZ (1) CZ286476B6 (no)
DE (3) DE122007000005I1 (no)
DK (1) DK0788496T3 (no)
ES (1) ES2155535T3 (no)
FI (1) FI119548B (no)
GR (1) GR3035519T3 (no)
HR (1) HRP950532B1 (no)
HU (1) HU219862B (no)
IL (1) IL115771A (no)
LU (1) LU91306I2 (no)
NO (1) NO311937B1 (no)
NZ (1) NZ295353A (no)
OA (1) OA10479A (no)
PT (1) PT788496E (no)
RO (1) RO118715B1 (no)
SK (1) SK281908B6 (no)
TR (1) TR199501295A2 (no)
WO (1) WO1996013499A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1028730B1 (en) * 1997-11-03 2002-04-17 Janssen Pharmaceutica N.V. Compositions of lipid lowering agents
SK15252000A3 (sk) * 1998-04-27 2001-10-08 Janssen Pharmaceutica N. V. Peleta, ktorej jadro je obalené činidlom znižujúcim lipidy a polymérom
US6451802B1 (en) * 1998-12-22 2002-09-17 Janssen Pharmaceutica N.V. S-oxide lipid lowering compounds
DE19945982A1 (de) * 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
US20050132022A1 (en) * 2003-12-12 2005-06-16 International Business Machines Corporation Computer system with LAN-based I/O
EP1708680A2 (en) * 2004-01-21 2006-10-11 Janssen Pharmaceutica N.V. Mitratapide oral solution
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
WO2005097131A2 (en) * 2004-04-09 2005-10-20 Janssen Pharmaceutica N.V. Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
CA2609783A1 (en) * 2005-05-27 2006-12-07 Pfizer Products Inc. Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
US20080269233A1 (en) * 2005-08-04 2008-10-30 Mark David Andrews Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
RS20080371A (en) * 2006-02-23 2009-07-15 Pfizer Limited, Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008059335A1 (en) 2006-11-13 2008-05-22 Pfizer Products Inc. Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
ATE474836T1 (de) * 2007-05-25 2010-08-15 Janssen Pharmaceutica Nv Verbesserte synthese von (2s-cis)-2-(brommethyl)- 2-(4-chlorphenyl)-1,3-dioxolan-4-methanol- methansulfonat(ester)
MX2011001405A (es) * 2008-08-06 2011-03-21 Pfizer Ltd Compuestos de diazepina y diazocano como agonistas de mc4.
EP2571871B1 (en) * 2010-05-19 2017-06-21 Sandoz AG Process for the preparation of chiral triazolones
IL277071B1 (en) 2018-03-08 2024-03-01 Incyte Corp Aminopyrizine diol compounds as PI3K–y inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4313953A (en) * 1978-06-23 1982-02-02 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
WO1994020063A2 (en) * 1993-03-04 1994-09-15 Cytoven International N.V. Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
US5521186A (en) * 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors

Also Published As

Publication number Publication date
MX9703074A (es) 1997-07-31
SK281908B6 (sk) 2001-09-11
DE122007000005I2 (de) 2008-04-24
FI971784A0 (fi) 1997-04-25
AU3868095A (en) 1996-05-23
ATE198889T1 (de) 2001-02-15
NZ295353A (en) 1998-08-26
HRP950532B1 (en) 2001-06-30
KR100227231B1 (ko) 1999-11-01
CZ286476B6 (en) 2000-04-12
IL115771A (en) 2000-02-29
OA10479A (en) 2002-04-09
AP9700968A0 (en) 1997-04-30
AP779A (en) 1999-11-03
JPH09511759A (ja) 1997-11-25
TR199501295A2 (tr) 1996-06-21
NO311937B1 (no) 2002-02-18
WO1996013499A1 (en) 1996-05-09
RO118715B1 (ro) 2003-09-30
DE122007000005I1 (de) 2007-04-26
HRP950532A2 (en) 1997-08-31
GR3035519T3 (en) 2001-06-29
CA2203274A1 (en) 1996-05-09
CN1068000C (zh) 2001-07-04
SK50797A3 (en) 1998-04-08
AU697744B2 (en) 1998-10-15
CY2256B1 (en) 2003-07-04
CZ119897A3 (cs) 1998-03-18
HU219862B (hu) 2001-08-28
AU697744C (en) 2002-08-22
CA2203274C (en) 2002-02-19
BR9509436A (pt) 1998-01-06
BG101402A (en) 1997-10-31
DE69519995D1 (en) 2001-03-01
ES2155535T3 (es) 2001-05-16
IL115771A0 (en) 1996-01-19
EP0788496B1 (en) 2001-01-24
FI971784A (fi) 1997-04-25
EP0788496A1 (en) 1997-08-13
DE69519995T2 (de) 2001-08-23
HUT77360A (hu) 1998-03-30
US5929075A (en) 1999-07-27
JP3025907B2 (ja) 2000-03-27
FI119548B (fi) 2008-12-31
BG63694B1 (bg) 2002-09-30
CN1161695A (zh) 1997-10-08
DK0788496T3 (da) 2001-06-18
PT788496E (pt) 2001-07-31
LU91306I2 (fr) 2007-03-19
NO971895D0 (no) 1997-04-24

Similar Documents

Publication Publication Date Title
NO971895D0 (no) Inhibitorer av apolipoprotein &lt;beta&gt;-syntesen
LV11178A (lv) 3-Ú4-(2-aminoetoksi) benzoil¾-2-aril-6-hidroksibenzoÚb¾tiofenu sintezes panemiens
FI980033A (fi) Solujen kiinnittymisen inhibiittoreita
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
EE9700093A (et) Apolipoproteiin-B sünteesi inhiibitorid
NO982716L (no) FremgangsmÕte og blandinger for syntese av dioksalan-nukleotider med &lt;beta&gt;-konfigurasjon
FI931408A0 (fi) Anordning foer fraesning av amorfiska staolremsor
NO20005187D0 (no) n-sats syntese av 2-oksazolidinonderivater
FI973591A0 (fi) Nya syntetiserade kryptofysiner
NO940912L (no) Rensing av kuldemedium
BR9607427A (pt) Inibiçao de angiogêne usando interleucina 12
BR9508380A (pt) Derivados de azalonas heterocíclicos anti-helicobacter
NO990832D0 (no) Syntese av bisendolylmalimider
NO963187D0 (no) Fremgangsmåte for syntese av gamma-pyroner
DE69433141D1 (de) Zusammensetzungen aus kohleteerschlamm
NO940190L (no) Anvendelse av alpha-ketoglutarat
FI970828A0 (fi) Spirostanyyliglykosidien kiteitä
NO952949D0 (no) Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider
FI942576A0 (fi) Behandling av plasma
NO953630D0 (no) Anvendelse av blandinger inneholdende acetaler
NO980501D0 (no) Fôring av rör
KR950024188U (ko) 갈치주낚용 도래의 고정구
IS4339A (is) Hömlun ljóssundurliðunar á 3-setnum-2-oxindólum
ITMI951551A0 (it) Composizioni orosolubili di n-acetilcisteina
UA852S (uk) Набір ваз

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

MM1K Lapsed by not paying the annual fees